Find-Health-Articles.com - making medical research available to everyone
Research article summary (published 30 Dec 2005):

[Megakaryopoietic cytokine levels in patients with essential thrombocythemia and their relationship with clinical and biochemical features]

(Niveles de citoquinas megacariocitopoyeticas en pacientes con trombocitemia esencial y su relacion con caracteristicas clinicas y bioquimicas.)

Full Abstract

Megakaryopoiesis and platelet production are driven by transcription factors and cytokines present in bone marrow environment. Essential thrombocythemia (ET) is a chronic myeloproliferative disorder characterized by high platelet count and megakaryocytic hyperplasia. In the present work we evaluated plasmatic levels of cytokines involved in megakaryocytic development in a group of patients with ET that were not on treatment, as well as thrombopoietin (TPO) levels before and during anagrelide treatment. The assays were carried out using ELISA techniques. Among the cytokines mainly involved in proliferation of megakaryocytic progenitors, interleukin 3 (IL-3) levels were found increased in patients compared to normal controls (p = 0.0383). Granulocyte-macrophage colony stimulating factor and stem cell factor levels were normal. Interleukin 6, as well as interleukin 11 and erythropoietin (EPO), cytokines mainly related to megakaryocytic maturation, were normal. Plasma TPO levels before treatment were within the normal range and increased during treatment but the difference was not statistically significant. Patients who displayed spontaneous platelet aggregation had higher plasma TPO levels compared to those who did not (p = 0.049). We did not find any relationship between cytokine levels and clinical or laboratory parameters. The high IL-3 levels seen in some patients with ET could contribute to megakaryocytic proliferation. The simultaneous occurrence of higher TPO levels and elevated platelet count could be a predisposing factor for the development of spontaneous platelet aggregation in ET patients.

 

Learn Faster Today      Improve your study skills

Author information

Author/s: Marta, Rosana F (RF); Goette, Nora P (NP); Molinas, Felisa C (FC);

Affiliation: Sección Hematología Investigación, Instituto de Investigaciones Médicas Alfredo Lanari, Facultad de Medicina, Universidad de Buenos Aires, Argentina. rfmarta(-atsign-)ciudad.com.ar

Journal and publication information

Publication Type: Controlled Clinical Trial; English Abstract; Journal Article

Journal: Medicina (Medicina (B Aires)), published in Argentina. (Language: spa)

Reference: 2006-; vol 66 (issue 6) : pp 540-6

Dates: Created 2007/01/23; Completed 2007/08/16; Revised 2008/11/21;

PMID: 17240625, status: MEDLINE (last retrieval date: 12/26/2008)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article (including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Associated Chemicals: Interleukin-3 (0) ; Platelet Aggregation Inhibitors (0) ; Quinazolines (0) ; Stem Cell Factor (0) ; anagrelide (0) ; Granulocyte-Macrophage Colony-Stimulating Factor (83869-56-1) ; Thrombopoietin (9014-42-0)

Related articles

These are the highest related articles currently in the database:

See 100+ related articles.

Related Article Map

12/30/1990
3/30/2005
Higher Relevance Score (15)
Lower Relevance Score (12)

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.

© Advanogy.com 2003-2009 (ACN 104 198 263) - All rights reserved. Terms of Use | Contact Us | Index